Journey Medical (DERM) Insider Trading & Ownership $7.56 +0.08 (+1.07%) As of 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Journey Medical (NASDAQ:DERM) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage13.16%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$609,521.67 Get DERM Insider Trade Alerts Want to know when executives and insiders are buying or selling Journey Medical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address DERM Insider Buying and Selling by Quarter Journey Medical Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/11/2025Claude MaraouiCEOSell49,271$5.01$246,847.71 3/7/2025Claude MaraouiCEOSell14,905$5.01$74,674.05 3/5/2025Claude MaraouiCEOSell18,147$5.13$93,094.11 3/3/2025Claude MaraouiCEOSell23,508$5.19$122,006.52 8/1/2024Joseph BeneschCFOSell9,324$5.47$51,002.28 7/23/2024Joseph BeneschCFOSell4,055$5.40$21,897.00 (Data available from 1/1/2013 forward) DERM Insider Trading Activity - Frequently Asked Questions Who is on Journey Medical's Insider Roster? The list of insiders at Journey Medical includes Claude Maraoui, Joseph Benesch, Justin Adam Smith, and Lindsay A Md Rosenwald. Learn more on insiders at DERM. What percentage of Journey Medical stock is owned by insiders? 13.16% of Journey Medical stock is owned by insiders. Learn more on DERM's insider holdings. Which Journey Medical insiders have been buying company stock? The following insiders have purchased DERM shares in the last 24 months: Claude Maraoui ($34,800.00), Justin Adam Smith ($104,100.00), and Lindsay A Md Rosenwald ($30,400.00). How much insider buying is happening at Journey Medical? Insiders have purchased a total of 50,000 DERM shares in the last 24 months for a total of $169,300.00 bought. Which Journey Medical insiders have been selling company stock? The following insiders have sold DERM shares in the last 24 months: Claude Maraoui ($536,622.39), and Joseph Benesch ($82,086.78). How much insider selling is happening at Journey Medical? Insiders have sold a total of 121,660 Journey Medical shares in the last 24 months for a total of $618,709.17 sold. Journey Medical Key ExecutivesDr. Lindsay Allan Rosenwald (Age 69)Executive Chairman Compensation: $50kMr. Claude Maraoui (Age 57)Founder, President, CEO & Director Compensation: $934.45k4 recent tradesMr. Joseph M. Benesch (Age 57)CFO & Corporate Controller Compensation: $409.04kMr. Andrew J. ZwibleVice President of OperationsMr. Ramsey Alloush (Age 38)General Counsel & Company Secretary Mr. Robert Nevin (Age 56)Chief Commercial Officer Jaclyn JaffeSenior Director of Corporate Operations More Insider Trading Tools from MarketBeat Related Companies ORGO Insider Ownership ANAB Insider Ownership PRTA Insider Ownership COGT Insider Ownership KROS Insider Ownership ARVN Insider Ownership QURE Insider Ownership BCYC Insider Ownership URGN Insider Ownership DNA Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market Sentiment This page (NASDAQ:DERM) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Collapse Is Already HereWhen a system is about to fail, those trained to spot it often notice before anyone else. Tim Plaehn flew high...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Journey Medical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Journey Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DERM Stock Free DERM Stock Alerts